Literature DB >> 20008844

Inhibition of Vascular Endothelial Growth Factor Receptor-1/Wnt/{beta}-catenin Crosstalk Leads to Tumor Cell Death.

Benjamin D Zeitlin1, Lee M Ellis, Jacques E Nör.   

Abstract

Two genes are considered synthetic lethal if mutation of either alone allows cell viability, whereas simultaneous mutation leads to cell death. A synthetic lethal screen unveiled the dependency of Wnt/beta-catenin-addicted colorectal cancer cells on vascular endothelial growth factor receptor-1 kinase activity and suggested a novel therapeutic approach for this malignancy. (Clin Cancer Res 2009;15(24):7453-5).

Entities:  

Year:  2009        PMID: 20008844      PMCID: PMC2796551          DOI: 10.1158/1078-0432.CCR-09-2578

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  12 in total

Review 1.  Wnt/beta-catenin signaling: components, mechanisms, and diseases.

Authors:  Bryan T MacDonald; Keiko Tamai; Xi He
Journal:  Dev Cell       Date:  2009-07       Impact factor: 12.270

2.  Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells.

Authors:  Fan Fan; Jane S Wey; Marya F McCarty; Anna Belcheva; Wenbiao Liu; Todd W Bauer; Ray J Somcio; Yan Wu; Andrea Hooper; Daniel J Hicklin; Lee M Ellis
Journal:  Oncogene       Date:  2005-04-14       Impact factor: 9.867

3.  Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia.

Authors:  X Zhang; J P Gaspard; D C Chung
Journal:  Cancer Res       Date:  2001-08-15       Impact factor: 12.701

Review 4.  Vascular endothelial growth factor (VEGF) signaling in tumor progression.

Authors:  Robert Roskoski
Journal:  Crit Rev Oncol Hematol       Date:  2007-02-26       Impact factor: 6.312

5.  Survival of cancer cells is maintained by EGFR independent of its kinase activity.

Authors:  Zhang Weihua; Rachel Tsan; Wei-Chien Huang; Qiuyu Wu; Chao-Hua Chiu; Isaiah J Fidler; Mien-Chie Hung
Journal:  Cancer Cell       Date:  2008-05       Impact factor: 31.743

Review 6.  Crosstalk between tumor cells and microenvironment via Wnt pathway in colorectal cancer dissemination.

Authors:  Dan Huang; Xiang Du
Journal:  World J Gastroenterol       Date:  2008-03-28       Impact factor: 5.742

Review 7.  VEGF-targeted therapy: mechanisms of anti-tumour activity.

Authors:  Lee M Ellis; Daniel J Hicklin
Journal:  Nat Rev Cancer       Date:  2008-07-03       Impact factor: 60.716

8.  Sequence- and target-independent angiogenesis suppression by siRNA via TLR3.

Authors:  Mark E Kleinman; Kiyoshi Yamada; Atsunobu Takeda; Vasu Chandrasekaran; Miho Nozaki; Judit Z Baffi; Romulo J C Albuquerque; Satoshi Yamasaki; Masahiro Itaya; Yuzhen Pan; Binoy Appukuttan; Daniel Gibbs; Zhenglin Yang; Katalin Karikó; Balamurali K Ambati; Traci A Wilgus; Luisa A DiPietro; Eiji Sakurai; Kang Zhang; Justine R Smith; Ethan W Taylor; Jayakrishna Ambati
Journal:  Nature       Date:  2008-03-26       Impact factor: 49.962

9.  A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene.

Authors:  Ji Luo; Michael J Emanuele; Danan Li; Chad J Creighton; Michael R Schlabach; Thomas F Westbrook; Kwok-Kin Wong; Stephen J Elledge
Journal:  Cell       Date:  2009-05-29       Impact factor: 41.582

10.  VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2.

Authors:  Z Zhang; K G Neiva; M W Lingen; L M Ellis; J E Nör
Journal:  Cell Death Differ       Date:  2009-10-16       Impact factor: 15.828

View more
  7 in total

1.  Resisting arrest: a switch from angiogenesis to vasculogenesis in recurrent malignant gliomas.

Authors:  Jeffrey P Greenfield; William S Cobb; David Lyden
Journal:  J Clin Invest       Date:  2010-02-22       Impact factor: 14.808

Review 2.  Utilizing targeted cancer therapeutic agents in combination: novel approaches and urgent requirements.

Authors:  Shivanni Kummar; Helen X Chen; John Wright; Susan Holbeck; Myrtle Davis Millin; Joseph Tomaszewski; James Zweibel; Jerry Collins; James H Doroshow
Journal:  Nat Rev Drug Discov       Date:  2010-10-29       Impact factor: 84.694

3.  miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1.

Authors:  Jonathon D Roybal; Yi Zang; Young-Ho Ahn; Yanan Yang; Don L Gibbons; Brandi N Baird; Cristina Alvarez; Nishan Thilaganathan; Diane D Liu; Pierre Saintigny; John V Heymach; Chad J Creighton; Jonathan M Kurie
Journal:  Mol Cancer Res       Date:  2010-11-29       Impact factor: 5.852

Review 4.  Telomeres and tissue engineering: the potential roles of TERT in VEGF-mediated angiogenesis.

Authors:  Fernando P Hartwig; Fernanda Nedel; Tiago V Collares; Sandra B C Tarquinio; Jacques E Nör; Flávio F Demarco
Journal:  Stem Cell Rev Rep       Date:  2012-12       Impact factor: 5.739

5.  Wnt3a expression is associated with MMP-9 expression in primary tumor and metastatic site in recurrent or stage IV colorectal cancer.

Authors:  Myung Ah Lee; Jin-Hee Park; Si Young Rhyu; Seong-Taek Oh; Won-Kyoung Kang; Hee-Na Kim
Journal:  BMC Cancer       Date:  2014-02-24       Impact factor: 4.430

6.  Impact of an altered Wnt1/β-catenin expression on clinicopathology and prognosis in clear cell renal cell carcinoma.

Authors:  Stephan Kruck; Christian Eyrich; Marcus Scharpf; Karl-Dietrich Sievert; Falco Fend; Arnulf Stenzl; Jens Bedke
Journal:  Int J Mol Sci       Date:  2013-05-24       Impact factor: 5.923

7.  MicroRNA-139-5p/Flt1/Wnt/β-catenin regulatory crosstalk modulates the progression of glioma.

Authors:  Qiong Wang; Bin Xu; Jixiang Du; Xinnv Xu; Chao Shang; Xiuyu Wang; Jinhuan Wang
Journal:  Int J Mol Med       Date:  2018-01-30       Impact factor: 4.101

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.